TD-9855
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for TD-9855, covering 2022-03-04 to 2023-01-20. Get the full timeline:
Most recent: Clinical Trial Update: Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure [Phase 3]